• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

Most of us are not normal…

Home / Patients / Most of us are not normal…

Genelex Blog

Most of us are not normal...

dna-iconRecent data suggests that most of us are not normal when it comes to drug metabolism because of our genetics.

In a recent retrospective analysis published in the American Journal of Health-Systems Pharmacy, the authors found that only 7% of over 14,000 patients tested were normal metabolizers for all five of the main drug metabolizing enzyme pathways (i.e., CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP3A5). The other 93% of patients had at least one ‘abnormal’ or ‘at-risk’ phenotype.

Pharmacogenetic testing for the CYP450 drug-metabolizing enzymes has been available for decades, albeit grossly underutilized.

Due to the high prevalence of abnormal phenotypes of the five main drug metabolizing enzymes which are responsible for breaking down the majority of medications in the liver, the authors suggest that routine pharmacogenetic testing makes sense in all patients.

Abnormal phenotypes range from Poor Metabolizers to Ultra Rapid Metabolizers. The clinical repercussions of these abnormal phenotypes include potential intolerances, early discontinuations, toxicities and treatment failures. Perhaps more important to note is that patients with these at-risk phenotypes may require dose modifications or use of alternative medications.  Fortunately, utilizing pharmacogenetic testing, we have a way to prevent some of these repercussions from occurring.

So we ask, “Are you normal?”

Learn how you can get tested here.

Genelex Resources

Affected Conditions
Affected Drugs
Info for Providers
Frequently Asked Questions
Contact Genelex
Join Our Mailing List

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.